Jazz Pharmaceuticals plc·4

Aug 22, 5:03 PM ET

Gray Peter 4

4 · Jazz Pharmaceuticals plc · Filed Aug 22, 2022

Insider Transaction Report

Form 4
Period: 2022-08-18
Gray Peter
Director
Transactions
  • Exercise/Conversion

    Ordinary Shares

    2022-08-18$55.28/sh+8,000$442,24022,234 total
  • Sale

    Ordinary Shares

    2022-08-18$158.00/sh8,000$1,264,00014,234 total
  • Exercise/Conversion

    Non-Qualified Stock Option (right to buy)

    2022-08-188,0000 total
    Exercise: $55.28Exp: 2023-05-08Ordinary Shares (8,000 underlying)
Footnotes (1)
  • [F1]This option was granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Option Plan. Subject to the Reporting Person's continuous service and certain additional conditions, this option vested over three years from the Vesting Commencement Date, with 1/3 that vested on the first anniversary of the Vesting Commencement Date and the remainder vested in 24 equal monthly installments thereafter.

Documents

1 file
  • 4
    edgardoc.xmlPrimary

    PRIMARY DOCUMENT